Globhy
AllBusinessHealthMarketingTechnologyTravelUncategorized
Posted on 53 minutes agoEdited on 53 minutes ago

Share:

United States Precision Medicine Market Size, Share, Growth, Trends, Industry Analysis & Forecast 2026–2034

United States Precision Medicine Market Size, Share, Growth, Trends, Industry Analysis & Forecast 2026–2034

Other important markets include Illinois, Pennsylvania, Ohio, Georgia, New Jersey, Washington, North Carolina, Massachusetts, Virginia, Michigan, and Colorado.

Competitive Landscape of the United States Precision Medicine Market

The competitive landscape includes pharmaceutical companies, biotechnology businesses, genomic sequencing providers, molecular diagnostic companies, and healthcare technology organizations.

Companies are focusing on research collaborations, diagnostic innovation, targeted therapeutics, genomic testing, and technology development to strengthen their market positions.

Major companies operating in the United States precision medicine market include:

  1. AstraZeneca plc
  2. Bayer AG
  3. bioMérieux SA
  4. Bristol Myers Squibb Company
  5. Eli Lilly and Company
  6. F. Hoffmann-La Roche AG
  7. Illumina Inc.
  8. Laboratory Corporation of America Holdings
  9. Merck KGaA
  10. Novartis AG

Competition is increasingly influenced by the ability to develop clinically validated diagnostic solutions, improve sequencing technologies, establish pharmaceutical partnerships, and integrate advanced data analytics into healthcare applications.

Future Outlook of the United States Precision Medicine Market

The future of the United States precision medicine market will be shaped by the convergence of genomics, artificial intelligence, advanced diagnostics, and personalized therapeutics.

Increasing availability of integrated genomic and clinical datasets will create new opportunities for understanding disease development and identifying treatment-related biomarkers. The expansion of multiomic technologies, including proteomics, RNA sequencing, and long-read sequencing, will further strengthen research capabilities.

Oncology is expected to remain a major application area because of increasing demand for biomarker-driven treatment selection and companion diagnostics.

At the same time, improvements in sequencing accuracy, laboratory automation, bioinformatics, and computational analysis may support broader clinical adoption.

However, addressing testing costs, insurance reimbursement, data privacy, clinical interpretation, and unequal access will remain important priorities.

With a projected market value of US$ 88.75 billion by 2034, the United States precision medicine industry is positioned for continued expansion, supported by technological innovation, biomedical research, and increasing demand for individualized healthcare solutions.

Frequently Asked Questions (FAQs)

1. What is the projected size of the United States precision medicine market by 2034?

The United States precision medicine market is projected to reach US$ 88.75 billion by 2034, increasing from US$ 39.54 billion in 2025.

2. What is the CAGR of the United States precision medicine market?

The market is expected to grow at a CAGR of 9.4% during the forecast period from 2026 to 2034.

3. What are the major factors driving precision medicine market growth in the United States?

Major growth drivers include increasing genomic testing, growing demand for targeted therapies, expanding clinical datasets, artificial intelligence integration, advanced sequencing technologies, and rising investments in biomedical research.

4. Which application dominates the United States precision medicine market?

Oncology is one of the most important application areas because molecular profiling, genetic biomarkers, companion diagnostics, and targeted therapies are increasingly influencing cancer treatment decisions.

5. Which technologies are used in precision medicine?

Share:

More in Business

View category
Complete Financial Protection: Key Person Insurance, Life Insurance and Senior Cover in the UK